LOGO-01.png
Burning Rock Secures Second NGS Kit Approval from the NMPA
March 15, 2022 09:38 ET | Burning Rock Biotech Limited
GUANGZHOU, China, March 15, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that the National Medical Products Administration...
LOGO-01.png
Burning Rock Schedules Fourth Quarter and Full Year 2021 Earnings Release on March 22, 2022
February 21, 2022 23:30 ET | Burning Rock Biotech Limited
GUANGZHOU, China, Feb. 22, 2022 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
LOGO-01.png
Burning Rock Reaffirms 2021 Revenue Guidance of RMB500 Million
December 28, 2021 20:05 ET | Burning Rock Biotech Limited
GUANGZHOU, China, Dec. 28, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that, based on the latest operating trends, the...
LOGO-01.png
Burning Rock Announces Results of 2021 Annual General Meeting
December 27, 2021 22:00 ET | Burning Rock Biotech Limited
GUANGZHOU, China, Dec. 27, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
LOGO-01.png
Merck KGaA, Darmstadt, Germany and Burning Rock Collaborate on Liquid-biopsy Based CDx Development Using Burning Rock’s OncoCompass Target™
November 17, 2021 20:15 ET | Burning Rock Biotech Limited
GUANGZHOU, China, Nov. 17, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced a strategic partnership with Merck KGaA, Darmstadt,...
LOGO-01.png
Burning Rock Reports Third Quarter 2021 Financial Results
November 15, 2021 20:30 ET | Burning Rock Biotech Limited
GUANGZHOU, China, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
LOGO-01.png
Burning Rock Collaborates with IMPACT Therapeutics to Provide Testing Services in Developing IMP9064 in both US and China
November 04, 2021 03:06 ET | Burning Rock Biotech Limited
GUANGZHOU, China, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced a collaboration with IMPACT Therapeutics where Burning...
LOGO-01.png
Burning Rock Schedules Third Quarter of 2021 Earnings Release on November 16, 2021
November 03, 2021 00:00 ET | Burning Rock Biotech Limited
GUANGZHOU, China, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company foused on the application of next generation sequencing...
LOGO-01.png
Burning Rock Schedules Second Quarter of 2021 Earnings Release on August 31, 2021
August 02, 2021 04:00 ET | Burning Rock Biotech Limited
GUANGZHOU, China, Aug. 02, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
LOGO-01.png
Burning Rock Reports First Quarter 2021 Financial Results
May 25, 2021 00:19 ET | Burning Rock Biotech Limited
GUANGZHOU, China, May 25, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...